ACUTA CAPITAL PARTNERS, LLC - CLEARSIDE BIOMEDICAL INC ownership

CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 47 filers reported holding CLEARSIDE BIOMEDICAL INC in Q3 2023. The put-call ratio across all filers is 1.66 and the average weighting 0.0%.

Quarter-by-quarter ownership
ACUTA CAPITAL PARTNERS, LLC ownership history of CLEARSIDE BIOMEDICAL INC
ValueSharesWeighting
Q3 2021$7,898,000
+23.2%
1,316,2680.0%2.79%
+8.8%
Q2 2021$6,410,000
+60.8%
1,316,268
-18.4%
2.56%
+78.2%
Q1 2021$3,987,000
+16.4%
1,614,000
+29.1%
1.44%
+54.3%
Q4 2020$3,425,000
+261.7%
1,250,000
+103.3%
0.93%
+262.6%
Q3 2020$947,000
-31.9%
615,000
+251.4%
0.26%
-22.1%
Q1 2017$1,390,000
-11.2%
175,0000.0%0.33%
-43.3%
Q4 2016$1,565,000175,0000.58%
Other shareholders
CLEARSIDE BIOMEDICAL INC shareholders Q3 2023
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 169,629$147,5600.05%
BROWN WEALTH MANAGEMENT, LLC 110,000$95,6890.05%
Carmignac Gestion 2,132,744$1,855,2740.03%
WATER ISLAND CAPITAL LLC 82,500$720.01%
Northeast Financial Consultants Inc 83,000$72,2020.01%
XTX Topco Ltd 27,545$23,9610.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 175,600$152,7540.00%
Curi Wealth Management, LLC 25,000$21,7480.00%
Banque Cantonale Vaudoise 40,000$350.00%
SYNOVUS FINANCIAL CORP 58,071$50,5160.00%
View complete list of CLEARSIDE BIOMEDICAL INC shareholders